The effectiveness of a health education intervention to reduce anxiety in quarantined COVID-19 patients: a randomized controlled trial
- PMID: 37340300
- PMCID: PMC10280925
- DOI: 10.1186/s12889-023-16104-w
The effectiveness of a health education intervention to reduce anxiety in quarantined COVID-19 patients: a randomized controlled trial
Abstract
Introduction: The COVID-19 pandemic is regarded as a serious public health concern that boosts levels of stress and anxiety which could be explained by several reasons, including social isolation. In this regard, we aimed to assess the impact of health education on the anxiety level of COVID-19 patients during the isolation period.
Methods: This is a randomized controlled trial conducted between February 2021 and June 2021. Patients tested positive for Covid-19 with mild to moderate forms were randomized to Education (n = 267) or control (n = 269). The education group received a phone health education session on day 1 (D1) following the diagnosis. The three components of the health education intervention were an explanation of the coronavirus disease, what to do in the event of complications, and the recommended preventive measures. The two groups received a telephone evaluation of their Hospital Anxiety and Depression scores on D1 and day seven D7 following the positive diagnosis. The primary outcome was the rate of anxiety reduction in each group on D7 based on a HAD-A score ≥ 8. Secondary outcomes were the rate of anxiety reduction on D7 based on a HAD-A score ≥ 11, the percentage of people complying with isolation and the scores of adherences to preventive measures during the isolation in each group.
Results: Hundred and ninety-six patients in the intervention group and 206 patients in the control group completed the study. The sociodemographic, clinical, and initial anxiety level features of the intervention and control groups were comparable at baseline (p ≥ 0.05). On D7, the education group's anxiety level (HAD-A ≥ 8) decreased from 26 to 16.3% (p = 0.013) while in the control group it increased from 19.4 to 22.8% (p = 0.37). Thus, the percentage change in anxiety between D1 and D7 (delta D7 - D1) was - 9.7% in the Education group and + 3.4% in the Control group. Using the HAD-A ≥ 11 thresholds, the percentage of anxiety decreased from 15.3 to 11.2% (p = 0.26) between D1 and D7, while it increased in the control group from 9.7 to 15.7% (p = 0.045). Thus, the education group's change in anxiety (delta D7 - D1) was - 4.1%, while the control group's change was + 6%.
Conclusion: During an outbreak, providing health education to quarantined patients may be beneficial to reduce the psychological impact of the disease.
Trial registration number: ClinicalTrials.gov Identifier: NCT05715593, retrospectively registered on 8/02/2023 https://clinicaltrials.gov/ct2/results?term=NCT05715593&Search=Search .
Keywords: Anxiety; COVID-19; Health education; Pandemic; Quarantine.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0. Trials. 2021. PMID: 33810796 Free PMC article.
-
Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial.Trials. 2020 Nov 25;21(1):968. doi: 10.1186/s13063-020-04872-4. Trials. 2020. PMID: 33239100 Free PMC article. Clinical Trial.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z. Trials. 2020. PMID: 32513289 Free PMC article.
-
Effectiveness and patient satisfaction of dental emergencies in Pitié Salpêtrière Hospital, Paris, during the COVID 19 pandemic.J Dent Anesth Pain Med. 2022 Aug;22(4):255-266. doi: 10.17245/jdapm.2022.22.4.255. Epub 2022 Jul 26. J Dent Anesth Pain Med. 2022. PMID: 35991364 Free PMC article.
Cited by
-
Implementing Pharmacogenomics Clinical Decision Support: A Comprehensive Tutorial on how to Integrate the Epic Genomics Module.Clin Pharmacol Ther. 2025 Jun;117(6):1670-1681. doi: 10.1002/cpt.3599. Epub 2025 Feb 17. Clin Pharmacol Ther. 2025. PMID: 39960348
-
Does coping style mediate the relationship between knowledge and psychosocial outcomes in women with atrial fibrillation?Front Psychiatry. 2024 Mar 22;15:1328111. doi: 10.3389/fpsyt.2024.1328111. eCollection 2024. Front Psychiatry. 2024. PMID: 38585480 Free PMC article.
-
Evaluating the impact of AI-generated educational content on patient understanding and anxiety in endodontics and restorative dentistry: a comparative study.BMC Oral Health. 2025 May 7;25(1):689. doi: 10.1186/s12903-025-06069-0. BMC Oral Health. 2025. PMID: 40335999 Free PMC article. Clinical Trial.
References
-
- WHO Coronavirus (COVID-19) Dashboard, https://covid19.who.int (accessed 31. May 2023).
-
- Tunisia. WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data, https://covid19.who.int (accessed 31 May 2023).
-
- #HealthyAtHome. https://www.who.int/campaigns/connecting-the-world-to-combat-coronavirus... (accessed 31 May 2023).
-
- Brahimi G, Larinouna A, Ait S et al. Etude épidémiologique des patients atteints de Covid- 19 reçus au CHU Béni- Messous du 11 Mars-30 Avril 2020: Résultats préliminaires. 7.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical